TY - JOUR
T1 - Older adult oncology, version 2.2016
T2 - Featured updates to the NCCN guidelines
AU - Van Der Walde, Noam
AU - Jagsi, Reshma
AU - Dotan, Efrat
AU - Baumgartner, Joel
AU - Browner, Ilene S.
AU - Burhenn, Peggy
AU - Cohen, Harvey Jay
AU - Edil, Barish H.
AU - Edwards, Beatrice
AU - Extermann, Martine
AU - Ganti, Apar Kishor P.
AU - Gross, Cary
AU - Hubbard, Joleen
AU - Keating, Nancy L.
AU - Korc-Grodzicki, Beatriz
AU - McKoy, June M.
AU - Medeiros, Bruno C.
AU - Mrozek, Ewa
AU - O'Connor, Tracey
AU - Rugo, Hope S.
AU - Rupper, Randall W.
AU - Shepard, Dale
AU - Silliman, Rebecca A.
AU - Stirewalt, Derek L.
AU - Tew, William P.
AU - Walter, Louise C.
AU - Wildes, Tanya
AU - Bergman, Mary Anne
AU - Sundar, Hema
AU - Hurria, Arti
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.
AB - Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.
UR - http://www.scopus.com/inward/record.url?scp=84994626854&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2016.0146
DO - 10.6004/jnccn.2016.0146
M3 - Review article
C2 - 27799507
AN - SCOPUS:84994626854
VL - 14
SP - 1357
EP - 1370
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
SN - 1540-1405
IS - 11
ER -